MIR34A and neoplasm: When the entire small intestinal tract from 18 weeks old ApcMin/+ mice was examined, Csf1r-deficient ApcMin/+ mice showed a significantly reduced number of intestinal tumors, whereas Mir34a-deficient mice showed a dramatic increase in tumor numbers (Fig. 2D-F).